Company Spotlight

Adare Pharma Solutions

1200 Lenox Drive
Princeton Pike Corporate Center, Suite 100
Lawrence Township, NJ 08648
United States
View Profile

Aphena Pharma Solutions, Inc.

1920 Fisk Road
Cookeville, TN 38506
United States
View Profile

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile


Contract Service Directory


Brad-Pak Enterprises, Inc.





Company Headquarters

124 south avenue
Garwood, NJ 07027
United States

Contract Service Directory

    Related Content

    • Analytical Services | Bioanalytical Services | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Formulation Development
      Contract Pharma’s 20th Anniversary Series: Ajinomoto Bio-Pharma

      Contract Pharma’s 20th Anniversary Series: Ajinomoto Bio-Pharma

      David Enloe of Ajinomoto Bio-Pharma Services shares his perspective on market changes over the years and the evolution of more integrated outsourcing
      Kristin Brooks, Contract Pharma 11.11.19

    • Breaking News | Industry News
      Alexion to Acquire Achillion in $930M Deal

      Alexion to Acquire Achillion in $930M Deal

      Will gain oral small molecule Factor D inhibitors to treat people with complement alternative pathway-mediated rare diseases
      10.18.19

    • Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News
      Astellas to Fund Boston-Area Cell and Gene Therapy Start-Up

      Astellas to Fund Boston-Area Cell and Gene Therapy Start-Up

      Invests $12.5 million to support LabCentral Incubators in Boston's Life Science Community
      10.01.19



    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | Validation
      CMAB Receives Positive Opinion Following External Quality Audit

      CMAB Receives Positive Opinion Following External Quality Audit

      CDMO’s fully integrated facility in Suzhou, China was found to conform to EU Eudralex Vol. 4 GMP guidelines
      09.10.19

    • Formulation Development | Industry News
      Enteris, Cara Therapeutics Enter Peptelligence Pact

      Enteris, Cara Therapeutics Enter Peptelligence Pact

      Cara has a non-exclusive, royalty-bearing license to the Peptelligence technology to develop, manufacture and commercialize Oral KORSUVA
      08.26.19


    • 18	ALLERGAN

      18 ALLERGAN

      ...
      07.15.19

    • Drug Development | Industry News
       Altimmune Signs Agreement to Acquire Spitfire Pharma

      Altimmune Signs Agreement to Acquire Spitfire Pharma

      Receives rights to NASH drug candidate, SP-1373
      07.09.19